Literature DB >> 16416268

Evaluation of a novel kit for the rapid detection of extended-spectrum beta-lactamases.

R Colodner1, B Reznik, V Gal, H Yamazaki, H Hanaki, R Kubo.   

Abstract

Since a method of rapidly detecting extended-spectrum beta-lactamase (ESBL) production in gram-negative isolates from patients with severe infection is urgently required, the present study of a novel commercial kit was conducted. The Cica-Beta Test I (Kanto Chemical, Tokyo, Japan) is designed for the rapid detection of ESBL in gram-negative bacteria directly from isolated colonies in a 15-min protocol. In this study, a total of 304 strains of Klebsiella spp., Escherichia coli and Proteus mirabilis were tested using the novel kit and the phenotypic confirmatory disk test using cefotaxime and ceftazidime with and without clavulanate. The kit showed 95.5 and 98.1% sensitivity and specificity, respectively, as compared to the disk test, and thus proved to be an appropriate tool for the rapid detection of ESBL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16416268     DOI: 10.1007/s10096-005-0074-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  5 in total

1.  Characterization of HMRZ-86: a novel chromogenic cephalosporin for the detection of extended-spectrum beta-lactamases.

Authors:  Hideaki Hanaki; Ryoichi Kubo; Tomota Nakano; Makoto Kurihara; Keisuke Sunagawa
Journal:  J Antimicrob Chemother       Date:  2004-03-31       Impact factor: 5.790

Review 2.  Is it important to identify extended-spectrum beta-lactamase-producing isolates?

Authors:  K Bush
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

Review 3.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

4.  OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.

Authors:  L M Hall; D M Livermore; D Gur; M Akova; H E Akalin
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

5.  Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals.

Authors:  D Gianneli; E Tzelepi; L S Tzouvelekis; A F Mentis; C Nikolopoulou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

  5 in total
  3 in total

1.  Risk factors of organ failure in cholangitis with bacteriobilia.

Authors:  Jae Min Lee; Sang Hyub Lee; Kwang Hyun Chung; Jin Myung Park; Ban Seok Lee; Woo Hyun Paik; Joo Kyung Park; Ji Kon Ryu; Yong-Tae Kim
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

2.  Risk factors of organ failure in patients with bacteremic cholangitis.

Authors:  Ban Seok Lee; Jin-Hyeok Hwang; Sang Hyub Lee; Sang Eon Jang; Eun Sun Jang; Hyun Jin Jo; Cheol Min Shin; Young Soo Park; Jin-Wook Kim; Sook-Hyang Jung; Nayoung Kim; Dong Ho Lee; Jun Kyu Lee; Soyeon Ahn
Journal:  Dig Dis Sci       Date:  2012-11-22       Impact factor: 3.199

Review 3.  Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition.

Authors:  Christina Alves Peixoto; Ana Karolina Santana Nunes; Ana Garcia-Osta
Journal:  Mediators Inflamm       Date:  2015-12-03       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.